Lanson BCC SA
LSE:0Q6P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lanson BCC SA
LSE:0Q6P
|
FR |
|
L
|
Lexicon Pharmaceuticals Inc
F:LX31
|
US |
Wall St Price Targets
0Q6P Price Targets Summary
Lanson BCC SA
According to Wall Street analysts, the average 1-year price target for 0Q6P is 35.0962 EUR with a low forecast of 32.0788 EUR and a high forecast of 38.5601 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0Q6P's stock price target?
Price Target
35.0962
EUR
According to Wall Street analysts, the average 1-year price target for 0Q6P is 35.0962 EUR with a low forecast of 32.0788 EUR and a high forecast of 38.5601 EUR.
What is the Revenue forecast for Lanson BCC SA?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Lanson BCC SA?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 3 years is 7%.
What is the Pre-Tax Income forecast for Lanson BCC SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Lanson BCC SA?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 3 years is 13%.
